Abstract:Background: Four transcription factors, Oct4, Sox2, Klf4, and c-Myc (the Yamanka factors), can reprogram somatic cells to induced pluripotent stem cells (iPSCs). Many studies have provided a number of alternative combinations to the non-Yamanaka factors. However, it is clear that many additional transcription factors that can generate iPSCs remain to be discovered. Methods: The chromatin accessibility and transcriptional level of human embryonic stem cells and human urine cells were compared by Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) and RNA sequencing (RNA-seq) to identify potential reprogramming factors. Selected transcription factors were employed to reprogram urine cells, and the reprogramming efficiency was measured. Urine-derived iPSCs were detected for pluripotency by Immunofluorescence, quantitative polymerase chain reaction, RNA sequencing and teratoma formation test. Finally, we assessed the differentiation potential of the new iPSCs to cardiomyocytes in vitro. Results: ATAC-seq and RNA-seq datasets predicted TEAD2, TEAD4 and ZIC3 as potential factors involved in urine cell reprogramming. Transfection of TEAD2, TEAD4 and ZIC3 (in the presence of Yamanaka factors) significantly improved the reprogramming efficiency of urine cells. We confirmed that the newly generated iPSCs possessed pluripotency characteristics similar to normal H1 embryonic stem cells. We also confirmed that the new iPSCs could differentiate to functional cardiomyocytes. Conclusions: In conclusion, TEAD2, TEAD4 and ZIC3 can increase the efficiency of reprogramming human urine cells into iPSCs, and provides a new stem cell sources for the clinical application and modeling of cardiovascular disease.

Generation of integration-free neural progenitor cells from cells in human urine

Generation of Urine Cell-Derived Non-integrative Human Ipscs and Inscs: A Step-by-Step Optimized Protocol.

Generation of Induced Pluripotent Stem Cells from Urine

Generating A Non-Integrating Human Induced Pluripotent Stem Cell Bank From Urine-Derived Cells

TGFβ signaling regulates the choice between pluripotent and neural fates during reprogramming of human urine derived cells

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Generation of human induced pluripotent stem cells from urine samples

Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells

Generation of Human Induced Pluripotent Stem Cells from Renal Epithelial Cells.

Direct Conversion of Human Urine Cells to Neurons by Small Molecules

Modeling Neurological Disease by Rapid Conversion of Human Urine Cells into Functional Neurons

A non-invasive method to generate induced pluripotent stem cells from primate urine

An Induced Pluripotent Stem Cells Line (Zzuneui022-A) Derived from Urine Cells of Healthy Male Human

Identification of New Transcription Factors that Can Promote Pluripotent Reprogramming

Endogenous retroviral ERVH48-1 promotes human urine cell reprogramming

Human Urinal Cell Reprogramming: Synthetic 3D Peptide Hydrogels Enhance Induced Pluripotent Stem Cell Population Homogeneity

Generation of Retinal Organoids with Mature Rods and Cones from Urine-Derived Human Induced Pluripotent Stem Cells

Generation of Hepatocyte-Like Cells from Human Urinary Epithelial Cells and the Role of Autophagy During Direct Reprogramming

Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients

Generation of integration-free and region-specific neural progenitors from primate fibroblasts.

Generation of Neural Progenitor Cells by Chemical Cocktails and Hypoxia